Physicians must choose from an ever-expanding arsenal of therapies intended to maintain lung health for patients with CF. There has been extensive research not only in the development of these medications, but also in their improved delivery. This workshop will focus on the safety & efficacy, as well as patient adherence in the evolving era of aerosolized medications.
Describe strategies for choosing nebulizers for the inpatient setting & minimizing immediate side effects of aerosolized therapies.
Discuss the long-term safety & efficacy of Tobramycin Inhalation Powder (TIPtm) & adherence to TIP(tm) versus Tobramycin Inhalation Solution.
Identify barriers to medication adherence & discuss the changes to adherence after using ivacaftor.